In vivo kinetic studies to further understand pathogenesis of abnormal lipoprotein metabolism in chronic kidney disease

Clinical and Experimental Nephrology

Volumn 18, Issue 2, 2014, Pages 261-264

  Ikewaki, Katsunori ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

apoA I; apoB containing lipoproteins; In vivo kinetics; Lp(a); Stable isotope

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; APOLIPOPROTEIN C; APOLIPOPROTEIN D; APOLIPOPROTEIN E; APOLIPOPROTEIN F; APOLIPOPROTEIN G; APOLIPOPROTEIN I; ATORVASTATIN; BETA2 GLYCOPROTEIN 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERMEDIATE DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STABLE ISOTOPE; UNCLASSIFIED DRUG; APOLIPOPROTEIN A1; LIPOPROTEIN;

ARTICLE; ATHEROGENESIS; CHRONIC KIDNEY DISEASE; COMPARTMENT MODEL; DISORDERS OF LIPOPROTEIN METABOLISM; HEMODIALYSIS PATIENT; HUMAN; IN VIVO STUDY; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; PATHOGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CHRONIC KIDNEY FAILURE; DYSLIPIDEMIA; KINETICS; METABOLISM; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY;

APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; DYSLIPIDEMIAS; HUMANS; KINETICS; LIPOPROTEINS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84899928181     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-013-0881-x     Document Type: Article

References (11)

1. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med. 1998;339:799-805. (Pubitemid 28447453)
2. Lindner A, Charra B, Sherrard DJ, et al. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med. 1974;290:697-701.
3. Kaysen GA. Hyperlipidemia of chronic renal failure. Blood Purif. 1994;12:60-7. (Pubitemid 24242712)
4. Ikewaki K, Rader DJ, Schaefer JR, et al. Evaluation of apoA-I kinetics in humans using simultaneous endogenous stable isotope and exogenous radiotracer methods. J Lipid Res. 1993;34: 2207-15. (Pubitemid 24000968)
5. Ikewaki K, Rader DJ, Sakamoto T, et al. Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency. J Clin Invest. 1993;92:1650-8. (Pubitemid 23304526)
6. Ikewaki K, Nishiwaki M, Sakamoto T, et al. Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency. J Clin Invest. 1995;96:1573-81.
7. Okubo K, Ikewaki K, Sakai S, et al. Abnormal HDL apolipoprotein A-I and A-II kinetics in hemodialysis patients: a stable isotope study. J Am Soc Nephrol. 2004;15:1008-15. (Pubitemid 38375319)
8. Frischmann ME, Kronenberg F, Trenkwalder E, et al. In vivo turnover study demonstrates diminished clearance of lipoprotein(a) in hemodialysis patients. Kidney Int. 2007;71:1036-43. (Pubitemid 46741981)
9. Schwaiger JP, Nakada Y, Berberich R, et al. Lipoprotein kinetics in male hemodialysis patients treated with atorvastatin. Clin J Am Soc Nephrol. 2013;8:1319-26.
10. Baigent C, Landray MJ, Reith C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet. 2011;377:2181-92.
11. Frischmann ME, Ikewaki K, Trenkwalder E, et al. In vivo stable-isotope kinetic study suggests intracellular assembly of lipoprotein(a). Atherosclerosis. 2012;225:322-7.